ZNF398 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.589200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.033800E-01
Normal-vs-Stage2
9.012800E-01
Normal-vs-Stage3
3.077800E-01
Normal-vs-Stage4
5.454800E-01
Stage1-vs-Stage2
4.818200E-01
Stage1-vs-Stage3
9.607700E-02
Stage1-vs-Stage4
7.338800E-01
Stage2-vs-Stage3
1.758230E-01
Stage2-vs-Stage4
2.828800E-01
Stage3-vs-Stage4
2.114600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.942200E-01
Normal-vs-AfricanAmerican
3.513400E-01
Normal-vs-Asian
8.883200E-01
Caucasian-vs-AfricanAmerican
2.684000E-01
Caucasian-vs-Asian
9.399200E-01
AfricanAmerican-vs-Asian
4.325200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.714400E-01
Normal-vs-Female
8.518600E-01
Male-vs-Female
9.284400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.422200E-01
Normal-vs-Age(41-60Yrs)
4.644600E-01
Normal-vs-Age(61-80Yrs)
9.437000E-01
Normal-vs-Age(81-100Yrs)
5.325800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.918400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.518200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.089220E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.141200E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.515600E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.630800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.240200E-01
Normal-vs-Daily Drinker
7.759200E-01
Normal-vs-Weekly Drinker
7.549000E-01
Normal-vs-Occasional Drinker
4.751800E-01
Normal-vs-Social Drinker
5.794600E-01
Non Drinker-vs-Daily Drinker
8.130400E-01
Non Drinker-vs-Weekly Drinker
2.074200E-01
Non Drinker-vs-Occasional Drinker
4.612000E-02
Non Drinker-vs-Social Drinker
8.384100E-02
Daily Drinker-vs-Weekly Drinker
2.775600E-01
Daily Drinker-vs-Occasional Drinker
9.046200E-02
Daily Drinker-vs-Social Drinker
1.151800E-01
Weekly Drinker-vs-Occasional Drinker
9.829200E-01
Weekly Drinker-vs-Social Drinker
8.112400E-01
Occasional Drinker-vs-Social Drinker
7.498600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.822800E-01
Normal-vs-Grade 2
9.903800E-01
Normal-vs-Grade 3
9.913200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.391800E-01
Grade 1-vs-Grade 3
8.860600E-01
Grade 1-vs-Grade 4
9.822800E-01
Grade 2-vs-Grade 3
6.588600E-01
Grade 2-vs-Grade 4
9.903800E-01
Grade 3-vs-Grade 4
9.913200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.555600E-01
Normal-vs-NonDiabetic
8.365200E-01
Diabetic-vs-NonDiabetic
2.141800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.245800E-01
Normal-vs-NoPancreatitis
9.163000E-01
Pancreatitis-vs-NoPancreatitis
5.087400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.001600E-01
Normal-vs-N1
8.978600E-01
N0-vs-N1
6.904600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.435800E-01
Normal-vs-TP53-NonMutant
5.788800E-01
TP53-Mutant-vs-TP53-NonMutant
2.735400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
